B72/100

Paramount Peptides🇺🇸

Finnrick A GREAT on Ipamorelin; mixed profile across 8 compounds — reliable for secretagogues, more variable on GLP-1 peptides.

Est. 201930+ compounds3rd-Party Tested$ Mid-Range
3.4
5 reviews
Visit site
🏆 #1 RATEDKylo Peptides tops our rankings on published, lot-matched third-party COAs
See Kylo Peptides

KYP Vendor Score

Methodology
B
72/100
Good
COA Transparency25/40
Community Rating20/30
Verified Status15/15
Longevity10/10
Review Volume1/5

Rating Breakdown

5
1
4
1
3
2
2
1
1
0
Country: United States
Established: 2019
Compounds: 30+

About Paramount Peptides

Paramount Peptides is a US-based research peptide supplier that has been operating since 2019, offering a focused catalog of roughly eight research compounds rather than a sprawling product list. Their range centers on growth hormone secretagogues such as Ipamorelin and CJC-1295, alongside GLP-1 class research peptides and a handful of recovery-focused compounds. Community feedback is strongest on their secretagogue line, where independent Finnrick testing has returned high marks for purity, while results on GLP-1 peptides have historically been more variable batch to batch.

On testing transparency, Paramount Peptides publishes third-party certificates of analysis (COAs) for their products, allowing researchers to verify identity and purity claims against an independent lab rather than relying on in-house numbers alone. Researchers should still match the COA lot number to the vial received, as documentation is not always issued per batch.

Ordering is handled through their website with standard domestic US shipping. Products ship lyophilized in sealed vials and, like all compounds in this category, are sold strictly for laboratory research use and not for human consumption. Researchers comparing suppliers should weigh Paramount's strong secretagogue track record against its mixed GLP-1 results and mid-tier overall KYP score.

KYP Editorial Review

Paramount Peptides earns a mid-tier KYP Vendor Score with a Grade B rating. They are a consistent mid-tier supplier with adequate COA documentation and a positive community reputation for the compounds they stock. This review covers their documentation program, catalog, pricing, shipping reliability, customer service, and what the community data tells us about the typical researcher experience when sourcing from them. The COA documentation at Paramount Peptides provides third-party testing coverage for catalog products. External laboratory analysis supports their certificates of analysis, which are accessible to customers and provide compound identity and purity data from independently conducted testing. This earns them a meaningful documentation score in our methodology and positions them above vendors who rely on in-house testing without external accountability. The program is functional and represents genuine quality investment appropriate for the mid-tier market position. As with other mid-tier vendors, the per-batch lot-specific traceability chain is not the primary feature of the Paramount Peptides documentation program. The external testing involvement is real and meaningful, but researchers should request batch-specific COA documentation at time of ordering to ensure they are working with documentation relevant to their specific lot rather than historical product-level certifications. The catalog covers core research peptides across the healing, performance, hormonal, and metabolic categories. The compound selection addresses the needs of most researchers working with well-characterized peptides in standard research applications. Core compounds are consistently available, and catalog management reflects a vendor focused on maintaining reliable stock of the compounds that drive the majority of demand. Pricing is in the mid range and is competitive within the vendor tier. Paramount Peptides positions their pricing to reflect the documentation standard they maintain and the reliable sourcing experience they deliver. The pricing is neither the lowest available nor the premium commanded by top-tier batch-certified vendors, which is appropriate for their market position. Shipping performance receives positive feedback in community reviews. Fulfillment is described as reliable with appropriate packaging for research peptide products throughout transit. Transit times are consistent with stated expectations and carrier standards for the product category. No systematic shipping failures appear in the review data. Customer service is described as professional and responsive in available community feedback. Communication is handled appropriately for routine inquiries and order concerns. Issue resolution is conducted fairly. The service experience is consistent with mid-tier vendor standards where interactions are competently managed. Community sentiment is positive across available reviews. Researchers describe satisfactory experiences with product quality on the compounds sourced, and the overall feedback reflects a vendor that delivers consistently on its mid-tier positioning. No major quality failures or systematic operational concerns appear in the review dataset. Researchers sourcing from Paramount Peptides should apply routine verification practices: review batch-specific COA documentation, confirm the testing laboratory source and accreditation, and plan independent verification for compounds where purity accuracy directly affects research protocol validity. Our recommendation: Paramount Peptides is appropriate as a secondary source in a diversified sourcing approach, providing mid-tier pricing and adequate documentation for common research compounds. For primary sourcing where the highest independent verification standards are required, Kylo Peptides and Core Peptides are the better choice. Paramount Peptides is a reliable mid-tier option for researchers who need supplementary sourcing or who are building a diversified vendor portfolio. Grade B. The role of Paramount Peptides in a well-structured sourcing strategy is as a reliable secondary source that supplements a Grade A primary vendor relationship for common compounds, without introducing the quality consistency concerns that some mid-tier vendors present. Their consistent community feedback and functional documentation program make them appropriate for this role without requiring the elevated scrutiny that vendors with more variable quality records demand. For researchers who are managing procurement costs across a large research program, having multiple reliable secondary vendors at the mid-tier level provides flexibility in timing purchases around pricing variations and stock availability. Paramount Peptides is a stable enough sourcing relationship to fill this role without the unpredictability that makes some mid-tier vendors unsuitable for regular sourcing. The verification practices appropriate for any mid-tier vendor remain the correct approach with Paramount Peptides regardless of their consistent community feedback. Community sentiment is an important signal but not a substitute for independent verification on compounds where accuracy directly affects research validity. The appropriate position of Paramount Peptides in a research sourcing portfolio is as a consistent and reliable secondary source for common compounds that supplements a Grade A primary relationship without introducing the complexity or quality uncertainty that some mid-tier vendors require. Their consistent community feedback and functional documentation program meet the basic requirements for mid-tier sourcing without the distinctive strengths or weaknesses that would make them either a compelling primary choice or a vendor to avoid. For researchers who are optimizing their sourcing portfolio for reliability and predictability rather than for the highest possible quality assurance at any cost, Paramount Peptides occupies a useful and appropriate position. The verification practices appropriate for mid-tier sourcing apply as always, and results accumulated across multiple orders build the personal quality baseline that informs long-term sourcing confidence.

-- KnowYourPeptide Research Team

Community Reviews(5 total)

Retatrutide and Semaglutide both tested poorly

GLP-1 Failure· May 9, 2026

Ordered both Retatrutide (C OKAY on Finnrick, 7.5/10) and Semaglutide (C OKAY, 6.3/10) from Paramount. Independent tests: 93.1% and 92.6% HPLC respectively. Both below research grade for compounds where accuracy matters. For GLP-1 peptides, Paramount is not the right choice. Their Ipamorelin A GREAT is a bright spot in an otherwise mixed catalog.

65 Finnrick samples — the data breadth is impressive, mixed results

Data Depth· May 9, 2026

65 samples across 8 compounds is a substantial Finnrick track record. The breadth of data gives useful visibility into their quality variance. The story it tells: exceptional on Ipamorelin, acceptable on some others, poor on Semaglutide. For researchers willing to be selective, there's genuine value here.

Semaglutide C OKAY on Finnrick — came back at 93.8% HPLC

Sema Disappointment· May 9, 2026

Paramount's Semaglutide scored 6.3/10 (C OKAY) on Finnrick. Independent test: 93.8% HPLC — below research grade for a GLP-1 compound where precise dosing is critical. Disappointing, especially given their Ipamorelin A GREAT performance. For Semaglutide, vendors like Koi, Peptide Sciences, and Skye Peptides are clearly better options.

Strong on secretagogues, variable on GLP-1 compounds

Category Selection· May 9, 2026

The pattern is clear in the Finnrick data: Ipamorelin A GREAT (8.2/10), Semaglutide C OKAY (6.3/10). My tests align. Use Paramount for Ipamorelin; use Koi for GLP-1 compounds. Their supply chain is clearly better optimized for secretagogues than incretin analogs. Selective ordering gives you strong value.

Ipamorelin A GREAT (8.2/10) — among the best scores for this compound

Ipamorelin Excellence· May 9, 2026

Paramount Peptides' Ipamorelin achieved 8.2/10 on Finnrick — an A GREAT score and among the highest for this compound across all vendors. My independent test: 98.1% HPLC. For Ipamorelin-specific research, Paramount is one of the top sources. Shame their quality doesn't carry over to all compounds.

AI Peptide Advisor

online · Claude + Gemini
ask your question...